secwatch.observer — SEC 8-K summary
======================================

Issuer:     NKGen Biotech, Inc. (—)
CIK:        0001845459
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001213900-24-105644
Event type: regulatory
Sentiment:  negative
Materiality: 0.60
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

NKGen Biotech receives Nasdaq non-compliance notice for MVPHS below $15M
------------------------------------------------------------------------

- Received Nasdaq notice on Dec 2, 2024: market value of publicly held shares below $15M requirement.
- Has 180 calendar days (until June 2, 2025) to regain compliance by closing at $15M+ for 10 consecutive business days.
- No immediate effect on listing; company may consider available options to regain compliance.
- If not regained, Nasdaq will issue delisting notice; company may appeal but no assurance of success.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024105644/0001213900-24-105644-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845459/000121390024105644/ea0223687-8k_nkgen.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-105644

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer